NEPHRON
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
26-08
micro format · 26 days late
2025
31-12
Financial
Highest result from 2023 to 2025net €209,039 ▲75.6%
The operating result of €274,353 and the net result of €209,039 are both a record.
31-12
Financial
Liquidity more than triplescurrent ratio 13.70
The current ratio rises from 3.76 to 13.70. Short-term debt falls from €52,440 to €27,773.
31-12
Financial
Equity above €200,000equity €371,490 ▲129%
With a profit in every financial year since 2023, equity grows to €371,490.
16-07
micro format · 15 days before the deadline
2024
31-12
Financial
Equity above €150,000equity €162,451 ▲274%
With a profit in every financial year since 2023, equity grows to €162,451.
09-07
micro format · 22 days before the deadline
2023
13-10
Gazette deed
IncorporationStarting capital €3,500 · Appointment: Othmane MOHIB (director) · Shareholding · Power of attorney10 points ▸
Gazette deed
Incorporation
Starting capital €3,500 · Appointment: Othmane MOHIB (director) · Shareholding · Power of attorney10 points ▸
- Othmane MOHIB holds 100 shares
- Power of attorney, Caroline Counet
- Incorporation, 05-10-2023
- Founder, Othmane MOHIB
- Founding capital, €3,500
- Other provision, “autorisations licences préalables ou conditions accès profession possibles, autorisation préalable” (deed in French)
- Registered office clause, “1200 Woluwe-Saint-Pierre,rue Saint-Henri,93” (deed in French)
- Board rule, 1
- Director appointment, Othmane MOHIB (director (not named in the articles))
- Pre-incorporation commitments, “takeover, engagements obligations et activités entreprises au nom et pour compte société en formation” (deed in French)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank